Biolife Solutions Stock Technical Analysis
| BLFS Stock | USD 21.80 0.78 3.45% |
As of the 1st of February, BioLife Solutions shows the Risk Adjusted Performance of (0.09), mean deviation of 1.78, and Standard Deviation of 2.58. BioLife Solutions technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm BioLife Solutions variance and potential upside to decide if BioLife Solutions is priced correctly, providing market reflects its regular price of 21.8 per share. Given that BioLife Solutions has information ratio of (0.16), we suggest you to validate BioLife Solutions's prevailing market performance to make sure the company can sustain itself at a future point.
BioLife Solutions Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as BioLife, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BioLifeBioLife Solutions' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Is there potential for Stock market expansion? Will BioLife introduce new products? Factors like these will boost the valuation of BioLife Solutions. Projected growth potential of BioLife fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about BioLife Solutions listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Investors evaluate BioLife Solutions using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating BioLife Solutions' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause BioLife Solutions' market price to deviate significantly from intrinsic value.
It's important to distinguish between BioLife Solutions' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BioLife Solutions should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, BioLife Solutions' market price signifies the transaction level at which participants voluntarily complete trades.
BioLife Solutions 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioLife Solutions' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioLife Solutions.
| 11/03/2025 |
| 02/01/2026 |
If you would invest 0.00 in BioLife Solutions on November 3, 2025 and sell it all today you would earn a total of 0.00 from holding BioLife Solutions or generate 0.0% return on investment in BioLife Solutions over 90 days. BioLife Solutions is related to or competes with Kestra Medical, Novocure, Azenta, STAAR Surgical, Phreesia, Pulse Biosciences, and Neogen. BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene ther... More
BioLife Solutions Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioLife Solutions' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioLife Solutions upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 17.79 | |||
| Value At Risk | (4.11) | |||
| Potential Upside | 3.19 |
BioLife Solutions Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioLife Solutions' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioLife Solutions' standard deviation. In reality, there are many statistical measures that can use BioLife Solutions historical prices to predict the future BioLife Solutions' volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.37) | |||
| Total Risk Alpha | (0.50) | |||
| Treynor Ratio | 3.62 |
BioLife Solutions February 1, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | 3.63 | |||
| Mean Deviation | 1.78 | |||
| Coefficient Of Variation | (710.70) | |||
| Standard Deviation | 2.58 | |||
| Variance | 6.65 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (0.37) | |||
| Total Risk Alpha | (0.50) | |||
| Treynor Ratio | 3.62 | |||
| Maximum Drawdown | 17.79 | |||
| Value At Risk | (4.11) | |||
| Potential Upside | 3.19 | |||
| Skewness | 0.623 | |||
| Kurtosis | 3.9 |
BioLife Solutions Backtested Returns
BioLife Solutions secures Sharpe Ratio (or Efficiency) of -0.14, which signifies that the company had a -0.14 % return per unit of risk over the last 3 months. BioLife Solutions exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm BioLife Solutions' Risk Adjusted Performance of (0.09), mean deviation of 1.78, and Standard Deviation of 2.58 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.1, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning BioLife Solutions are expected to decrease at a much lower rate. During the bear market, BioLife Solutions is likely to outperform the market. At this point, BioLife Solutions has a negative expected return of -0.36%. Please make sure to confirm BioLife Solutions' potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if BioLife Solutions performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.25 |
Poor predictability
BioLife Solutions has poor predictability. Overlapping area represents the amount of predictability between BioLife Solutions time series from 3rd of November 2025 to 18th of December 2025 and 18th of December 2025 to 1st of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioLife Solutions price movement. The serial correlation of 0.25 indicates that over 25.0% of current BioLife Solutions price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.25 | |
| Spearman Rank Test | 0.04 | |
| Residual Average | 0.0 | |
| Price Variance | 1.17 |
BioLife Solutions technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
BioLife Solutions Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of BioLife Solutions volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About BioLife Solutions Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of BioLife Solutions on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of BioLife Solutions based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on BioLife Solutions price pattern first instead of the macroeconomic environment surrounding BioLife Solutions. By analyzing BioLife Solutions's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of BioLife Solutions's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to BioLife Solutions specific price patterns or momentum indicators. Please read more on our technical analysis page.
BioLife Solutions February 1, 2026 Technical Indicators
Most technical analysis of BioLife help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for BioLife from various momentum indicators to cycle indicators. When you analyze BioLife charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | 3.63 | |||
| Mean Deviation | 1.78 | |||
| Coefficient Of Variation | (710.70) | |||
| Standard Deviation | 2.58 | |||
| Variance | 6.65 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (0.37) | |||
| Total Risk Alpha | (0.50) | |||
| Treynor Ratio | 3.62 | |||
| Maximum Drawdown | 17.79 | |||
| Value At Risk | (4.11) | |||
| Potential Upside | 3.19 | |||
| Skewness | 0.623 | |||
| Kurtosis | 3.9 |
BioLife Solutions February 1, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as BioLife stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.04 | ||
| Daily Balance Of Power | (0.77) | ||
| Rate Of Daily Change | 0.97 | ||
| Day Median Price | 22.29 | ||
| Day Typical Price | 22.12 | ||
| Price Action Indicator | (0.87) | ||
| Market Facilitation Index | 1.01 |
Additional Tools for BioLife Stock Analysis
When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.